Inhibrx Biosciences Inc (INBX)
R&D Expenses
$102.47M
TTM · Period ending: · USD
INBX R&D Expenses
Latest reported$102.47Mperiod ending
Latest reported$102.47Mperiod ending
INBX TTM R&D Expenses ($31.24M → $102.47M)
TTM R&D Expenses
High-resolution chart · PNG
INBX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 102,470,000 | |
| 100,838,000 | |
| 113,028,000 | |
| 121,046,000 | |
| 130,744,000 | |
| 176,109,000 | |
| 202,827,000 | |
| 251,299,000 | |
| 251,123,000 | |
| 217,355,000 | |
| 190,909,000 | |
| 139,521,000 | |
| 126,398,000 | |
| 122,440,000 | |
| 110,186,000 | |
| 98,350,000 | |
| 91,901,000 | |
| 79,897,000 | |
| 71,440,000 | |
| 70,493,000 | |
| 71,845,000 | |
| 72,917,000 | |
| 73,495,000 | |
| 68,110,000 | |
| 61,058,000 | |
| 54,258,000 | |
| 47,907,000 | |
| 40,304,000 | |
| 36,014,000 | |
| 34,619,000 | |
| 31,243,000 |